{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:58:30Z","timestamp":1781679510858,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cellsig.2025.112168","type":"journal-article","created":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T14:24:35Z","timestamp":1760279075000},"page":"112168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["HOXA13 promotes prostate cancer metastasis by inhibiting ferroptosis via upregulating SLC7A11 and SLC3A2"],"prefix":"10.1016","volume":"136","author":[{"given":"Yongliang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongtao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2025.112168_bb0005","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112168_bb0010","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41420-023-01430-0","article-title":"Ferroptosis landscape in prostate cancer from molecular and metabolic perspective","volume":"9","author":"Liang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112168_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/biom13121715","article-title":"Caspase-linked programmed cell death in prostate Cancer: from apoptosis, necroptosis, and Pyroptosis to PANoptosis","volume":"13","author":"Zhu","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112168_bb0020","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"14","key":"10.1016\/j.cellsig.2025.112168_bb0025","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.7150\/thno.57803","article-title":"An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment","volume":"11","author":"Hsieh","year":"2021","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112168_bb0030","first-page":"1547","article-title":"p62 promotes proliferation, apoptosis-resistance and invasion of prostate cancer cells through the Keap1\/Nrf2\/ARE axis","volume":"43","author":"Jiang","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cellsig.2025.112168_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175913","article-title":"Understanding sorafenib-induced ferroptosis and resistance mechanisms: implications for cancer therapy","volume":"955","author":"Li","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112168_bb0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112168_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112238","article-title":"HOXA13 promotes colon cancer progression through \u03b2-catenin-dependent WNT pathway","volume":"395","author":"Gu","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112168_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40164-022-00260-7","article-title":"HOXA13 promotes gastric cancer progression partially via the FN1-mediated FAK\/Src axis","volume":"11","author":"Qin","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112168_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10142-025-01553-w","article-title":"HOXA13 promotes immune evasion in bladder cancer by suppressing antigen processing and presentation, and phagosome pathways","volume":"25","author":"Chin","year":"2025","journal-title":"Funct. Integr. Genomics"},{"issue":"17","key":"10.1016\/j.cellsig.2025.112168_bb0060","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2217\/fon-2016-0522","article-title":"HOXA13 is associated with unfavorable survival and acts as a novel oncogene in prostate carcinoma","volume":"13","author":"Dong","year":"2017","journal-title":"Future Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112168_bb0065","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.7150\/ijbs.72629","article-title":"UBE2S as a novel ubiquitinated regulator of p16 and \u03b2-catenin to promote bone metastasis of prostate cancer","volume":"18","author":"Peng","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112168_bb0070","article-title":"The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signaling","volume":"10","author":"Li","year":"2020"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112168_bb0075","article-title":"LncRNA CEBPA-DT promotes liver cancer metastasis through DDR2\/\u03b2-catenin activation via interacting with hnRNPC","volume":"41","author":"Yunshi","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112168_bb0080","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))","volume":"25","author":"L","year":"2002","journal-title":"Method. Methods"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112168_bb0085","article-title":"SPDEF enhances cancer stem cell-like properties and tumorigenesis through directly promoting GALNT7 transcription in luminal breast cancer","volume":"14","author":"Jingyuan","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.112168_bb0090","doi-asserted-by":"crossref","unstructured":"Ziwei, W., et al., Sodium butyrate induces ferroptosis in endometrial cancer cells via the RBM3\/SLC7A11 axis. Apoptosis, 2023. 28(0).","DOI":"10.1007\/s10495-023-01850-4"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112168_bb0095","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2025.112168_bb0100","article-title":"HOXA13, negatively regulated by miR-139-5p, decreases the sensitivity of gastric Cancer to 5-fluorouracil possibly by targeting ABCC4","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112168_bb0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1620\/tjem.234.209","article-title":"Overexpression of HOXA13 as a potential marker for diagnosis and poor prognosis of hepatocellular carcinoma","volume":"234","author":"Pan","year":"2014","journal-title":"Tohoku J. Exp. Med."},{"issue":"29","key":"10.1016\/j.cellsig.2025.112168_bb0110","doi-asserted-by":"crossref","first-page":"27778","DOI":"10.18632\/oncotarget.4813","article-title":"HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-\u03b2 pathways","volume":"6","author":"Duan","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112168_bb0115","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","article-title":"Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer","volume":"40","author":"Yang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.cellsig.2025.112168_bb0120","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152067","article-title":"RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11","volume":"131","author":"Zhang","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112168_bb0125","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41419-022-04971-x","article-title":"STAT6 inhibits ferroptosis and alleviates acute lung injury via regulating P53\/SLC7A11 pathway","volume":"13","author":"Yang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112168_bb0130","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.immuni.2021.04.014","article-title":"Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential","volume":"54","author":"Procaccini","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.cellsig.2025.112168_bb0135","series-title":"A Multifunctional Nanocatalytic Metal-Organic Framework as a Ferroptosis Amplifier for Mild Hyperthermia Photothermal Therapy","first-page":"0397","volume":"7","author":"Deng","year":"2024"},{"key":"10.1016\/j.cellsig.2025.112168_bb0140","series-title":"A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy","first-page":"0735","volume":"8","author":"Zhang","year":"2025"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825005832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825005832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:47:10Z","timestamp":1781678830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825005832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"alternative-id":["S0898656825005832"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112168","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HOXA13 promotes prostate cancer metastasis by inhibiting ferroptosis via upregulating SLC7A11 and SLC3A2","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112168"}}